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Abstract

Treatment of cervical cancer includes combination of external beam radiation therapy (EBRT) and brachytherapy
(BRT). Traditionally, coronal images displaying dose distribution from a ring and tandem (R&T) implant aid in construction
of parametrial boost fields. This research aimed to evaluate a method of shaping parametrial fields utilizing contours
created from the high-dose-rate (HDR) BRT dose distribution.
Eleven patients receiving HDR-BRT via R&T were identified. The BRT and EBRT CT scans were sent to FocalSim
(v4.62)® and fused based on bony anatomy. The contour of the HDR isodose line was transferred to the EBRT scan.
The EBRT scan was sent to CMS-XIO (v4.62)® for planning. This process provides an automated, potentially more accurate method of matching the medial parametrial border to the HDR dose distribution. This allows for a 3D-view
of dose from HDR-BRT for clinical decision-making, utilizes a paperless process and saves time over the traditional
technique.
J Contemp Brachytherapy 2013; 5, 1: 50–54
DOI: 10.5114/jcb.2013.34341
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Purpose

Radiation therapy has been established as an effective
component of definitive treatment of patients with invasive
cervical cancer. Current guidelines recommend a cumulative EQD2, equivalent dose in 2 Gy fractionation of 75-85 Gy
to the parametrial tissues [1-3]. This is typically delivered with a combination of external beam radiation therapy
(EBRT) and brachytherapy (BRT). Combination therapy allows for delivery of increased dose to tumor while sparing
surrounding normal tissue. A portion of the EBRT dose is
often delivered as a parametrial/pelvic sidewall boost that
spares midline structures. A variety of techniques have been
used to design the parametrial boost fields and are described
in the literature [4-6]. It is imperative that each phase of radiotherapy (EBRT, brachytherapy, and parametrial boost)
is designed and implemented properly as increased local
control and survival are expected when the entire treatment
course delivers the appropriate dose and is completed within eight weeks [1,7,8].
At our institution, cervical cancer patients are typically
treated with a traditional 4-field, conformal pelvis technique,
a parametrial boost plan with parallel-opposed AP and PA
fields, and high dose rate (HDR) intracavitary brachytherapy. Our practice to date has been to manually design the
parametrial boost fields, so that they are situated immediately lateral to the 50% isodose lines of the HDR brachy-

therapy plans. In this report, we explore a simple, elegant,
image-based method of designing the parametrial boost
fields by utilizing contours created from HDR BRT dose distribution using computer-based planning.

Material and methods
Patient selection

Eleven consecutive patients with locally advanced cervical carcinoma (stage IIB – 10, and IIIB – 1) treated between
August 2009 and October 2011 were identified. Nine of the
eleven patients had bilateral parametrium involvement. All
patients were treated at a single institution for all components of radiation therapy. Fractionation schemes include
initial external beam to the whole pelvis for 45 Gy in 25 fractions, total brachytherapy doses ranging from 29-35 Gy in
5 fractions and parametrial boost doses of 5.4-14.4 Gy in
3-8 fractions (1.8 Gy/fraction).

Treatment planning objectives

All patients were treated with external beam radiation
therapy (EBRT) for whole pelvis irradiation followed by intracavitary brachytherapy and a boost to the parametrium.
CT image sets were obtained for EBRT and BRT planning
using GE-LightSpeed 16-slice scanner® (GE Healthcare, Wau-
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kesha, WI, USA). EBRT planning was performed using CMS
XIO 4.62® (Nucletron, an Elekta company, Elekta AB,
Stockholm, Sweden). Traditional four-field, conformal
RT technique was used for the initial pelvis fields to a total dose of 45 Gy using standard dose/fractionation scheme
of 1.8 Gy daily fractions over the course of 5 weeks. One patient received two larger fractions of 3 Gy at the onset of therapy to control bleeding. Towards the end of the EBRT course,
all patients received HDR brachytherapy on non-EBRT days
with an effort to keep total treatment time within eight
weeks. All patients were treated with a CT/MR compatible
intrauterine ring, tandem applicator of varying size, angulations and Nucletron V2 afterloader® (Nucletron, an Elekta company, Elekta AB, Stockholm, Sweden). The brachytherapy dose was prescribed to point A, 2 cm superior and
2 cm lateral to the cervical os, as defined by the superior surface of the ring, detailed in the American Brachytherapy Society consensus guidelines [3] . All brachytherapy planning
was performed using Oncentra MasterPlan 3.2® (Nucletron,
an Elekta company, Elekta AB, Stockholm, Sweden). All parametrial boost plans were achieved with aperture-based
parallel-opposed anterior and posterior fields. Planning of
the boost fields was performed immediately following the
first fraction of HDR brachytherapy to ensure no gap in treatment.

Aperture design of boost fields

Current procedure requires a single coronal slice, displaying the isodose lines resulting from patient’s first HDR
BRT treatment printing. The physician then designs the
boost fields on EBRT planning CT by visually matching medial field borders to the 50% isodose line displayed on paper, and evaluates dose to the target volume and critical
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structures. For this study, the CT image-set and three-dimensional dose distribution from each patient’s first ring
and tandem HDR brachytherapy fraction was exported to
MIM Vista 5.1 (Fig. 1). Each case was loaded in MIM Vista
and the 50% isodose surface (IDS) was converted into a contour. The CT image-set and the structure set containing the
50% IDS contour was transferred to FocalSim 4.62® (Elekta company, Elekta AB, Stockholm, Sweden) where it was
fused to the EBRT planning CT image-set (Fig. 2). Due to
soft tissue deformation caused by the intrauterine applicator, the fusion was assessed solely on bony anatomy. Once
fused, the 50% IDS contour was copied to the EBRT planning CT image-set. In CMS XIO® (Elekta company, Elekta AB, Stockholm, Sweden), the original parametrial boost
plan based on single coronal slice showing isodose lines was
loaded (Table 1). The medial border of the existing anterior field edge was adjusted to conform to the 50% IDS contour (Fig. 3). This process was repeated for the posterior
field edge. Dose normalization was matched to the original plan.

Plan assessment

Field size as indicated by blocked equivalent square was
analyzed for initial and edited plan. Volume of irradiated
tissue was assessed in MIM by creating contours from the
85%, 90%, and 95% isodose lines using the process described above. The volume encompassed by these lines was used
for comparison.

Results

Nine of eleven patients were clinically deemed to require
bilateral boost fields to left and right parametrial nodes.

Fig. 1. Dose distribution of typical ring and tandem implant shown in axial, sagittal and coronal planes. Plan generated in
brachytherapy module of Oncentra MasterPlan and dose normalized to point A
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Fig. 2. Axial slices showing fusion of external beam planning CT image-set and brachytherapy planning CT image-set in FocalSim. The 30% and 50% isodose surfaces are shown on brachytherapy planning CT

Table 1. Field size as indicated by blocked equivalent square in CMS XIO
Blocked Equivalent Square (cm)
Initial Boost
Right
AP

Replanned Boost
L e ft

PA

AP

Right
PA

AP

Difference

L e ft
PA

Right

AP

PA

AP

L e ft
PA

AP

PA

Mean

4.54

4.61

4.51

4.50

3.94

4.10

3.90

3.96

0.60

0.51

0.61

0.54

Standard deviation

0.97

0.94

0.53

0.59

0.94

0.96

0.70

0.61

0.78

0.75

0.63

0.56

Fig. 3. Left image shows original MLC aperture based on hardcopy images of coronal slices from HDR plan. Right image shows
the same MLC aperture with medial border conformed to the contour of the 50% isodose surface

Thus, 20 parametrial regions were treated, each with two
fields (AP and PA). Of 40 fields analyzed, 7 increased and
33 decreased in size when this novel technique was used.
Initial field sizes ranged from 2.94 cm to 6.36 cm. Replanned field sizes ranged from 2.61 cm to 5.98 cm. The mean
change in field size was a decrease of 0.56 cm (range: –0.17
to 2.05 cm). The volumes encompassed by the 95%, 90%,
and 80% isodose surfaces of the parametrial boost fields decreased by an average of 23.1 cc, 48.5 cc, and 71.1 cc, re-

spectively (Table 2). These changes were all statistically significant (p < 0.05) using paired Student’s t-test.

Discussion

This work presents results of a novel technique for shaping parametrial fields based on contours formed from HDR
BRT dose distributions. For a majority of patients, designing parametrial fields based on the contour derived from
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the 50% IDS resulted in a decrease in field size as indicated by the blocked equivalent square and volume of irradiated tissue. The goal of parametrial field design is to supplement central dose distribution from HDR brachytherapy
to extend laterally into parametrial nodal regions, providing a total dose of 50-55 Gy to this area treated with initial
whole pelvis EBRT. Thus, the field design is dependent upon
HDR dose distribution. Although the classic pear shaped
distribution created by the ring and tandem applicator is
fairly consistent, there are slight changes in shape and size
due to different combinations of applicator lengths and angles. Traditional methods rely on the clinician to qualitatively match the border of the HDR dose distribution. In
the era of 3D brachytherapy dose calculations and ease of
DICOM transfer, the method proposed in this work allows
for quantitative assessment of field design and improves consistency in the process of field design. Although quantitative time analysis for the two techniques was not conducted, the proposed technique can be completed in less than
15 minutes. Optimal design of parametrial fields should be
established to avoid possible over- or under-dosing of the
nodal regions. It has been shown that high dose to the parametrium can result in an increased likelihood of developing radiation proctitis [9] and enterocolitis [10]. As stated,
this technique resulted in a reduction of field size in 82.5%
of parametrial fields indicating a likely decrease in possibility of regions of increased dose. For treatment using
techniques other than traditional anterior/posterior fields,
contours of various isodose surfaces could serve as avoidance structures. This method could further reduce overdosing pelvic sidewall regions. Future research should be
done to include total composite dose assessment from all
treatment modalities, however this task is complicated by
the need for deformable registration and equivalent dose
considerations.
There are several limitations to this study. In our clinical practice, a new plan is generated for each R&T implant.
In this study, however, the isodose contour used to shape
the medial border of the parametrial field represents dose
distribution from a single fraction. Differences in dose distributions between fractions were not considered. In addition, our sample size of eleven patients was limited. More
subtle differences between the fields generated with each
technique may be identified if more patients are studied.
This study did not address many advances in brachytherapy of the cervix, including use of MR imaging in contouring and planning or prescription to a high risk clinical
target volume as recommended by the American Brachytherapy Society [3]. There are a number of manuscripts describing the advantages of MRI in delineating the high risk
clinical target volume HR-CTV and critical organs at risk
described by the GEC-ESTRO working group [11]. There
are also advantages to MRI in the pre-planning setting [12],
and to utilize volume based planning to decrease the variability seen when prescribing to point A, including the
changes in the definition of Point A over time [13]. Although
MR guidance and target volume delineation is ideal, a recent study found that approximately 77% of institutions in
the United States still prescribe to Point A [14]. This technique we describe may be utilized regardless of brachytherapy planning technique as a way to better design parametrial fields around the brachytherapy dose distribution.

53

Table 2. Change in volume of tissue encompassed
by 95%, 90%, and 80% isodose surfaces after replan
Mean

Standard deviation

40.05

95% IDL (cc)
Initial Boost

Right

64.10

Left

65.78

42.14

Replanned Boost

Right

50.10

48.18

Left

35.28

22.53

Difference

Right

14.00

24.09

Left

30.51

30.51

Right

164.46

96.58

Left

159.64

76.13

Right

124.30

107.30

Left

104.23

50.47

Right

40.16

62.96

Left

55.40

48.02

Initial Boost

Right

340.35

138.48

Left

305.78

83.10

Replanned Boost

Right

263.02

138.23

Left

238.67

89.36

Difference

Right

77.33

108.84

Left

67.11

59.34

90% IDL (cc)
Initial Boost

Replanned Boost

Difference

80% IDL (cc)

Conclusions

The size and shape of the parametrial boost fields
changed relatively consistently, but not dramatically, by conforming the medial field edge to the contour of the 50% isodose line from the HDR plan. While the clinical implications
of these changes are difficult to predict, this technique may
lead to more efficient and reliable treatment planning. This
process provides a simple, automated, potentially more accurate, method of matching the medial parametrial border
to the HDR dose distribution, provides a 3D view of the dose
from HDR BRT for clinical decision making, utilizes a paperless process and may save time over the traditional technique. However, accuracy is highly dependent on image fusion of HDR and EBRT CTs, which remains difficult due to
differences in patient setup and tissue deformation. In all
cases, the fusion process requires additional physician review and approval.
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